BMS, Qiagen pharmacogenetics deal

Bristol-Myers Squibb Co. (NYSE:BMY) and Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) partnered to use next-generation sequencing technology to develop gene expression profiles in order to predict patient res...